R-EXOs can increase immunosuppressive cells such as Tregs, myeloid-derived suppressor cells (MDSCs) and TGF-β-secreting cells at tumor sites while directly inhibiting effector antitumoral T cells [29, 46]. Here, TGFB1 is linked to neoplasm.